Memorial Sloan Kettering Cancer Center (MSK) announced today that physician-scientist Karuna Ganesh, MD, PhD, has been awarded a Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems in cancer research. Dr. Ganesh is part of an international team focused on developing new ways to “rewire” cancer cells and prevent treatment resistance in colorectal cancer, one of the leading causes of cancer-related deaths worldwide, and with rates rising among adults under 50.
Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.
Metastasis remains the primary challenge to reducing cancer deaths worldwide. A new MSK study is providing unique insights that researchers say point to new therapeutic opportunities.
Hear the latest research about what may be contributing to the alarming trend of young people getting cancer earlier in their lives than previous generations.
Hear from three women breaking new ground in the fields of cancer metastasis, immunology and philanthropy.
Feature
Through converging lines of research in stem cell biology, tissue regeneration, and immunity, Sloan Kettering Institute scientists are learning what makes metastatic cancer cells tick.
In the Lab
Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.
